Yew Bio Pharm Balance Sheet - Quarterly (OTCBB:YEWB)

Add to My Stocks
$0.3 $0 (0%) YEWB stock closing price Jul 20, 2018 (Closing)

The Yew Bio Pharm balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Yew Bio Pharm stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Apart from analyzing Yew Bio Pharm revenue Yew Bio Pharm operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Yew Bio Pharm balance sheet for 2018 Q1 shows cash on hand of $-. The company has a debt to equity ratio of 0.15.

View and download Yew Bio Pharm quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Marketable Securities----------
Raw Materials--4.84M5.5M7.39M5.06M--4.28M3.33M
Work In Progress----------
Finished Goods3.49M2.47M4.51M8.82M3.33M5.24M11.94M7.97M5.48M1.33M
Notes Receivable----------
Other Current Assets--------1.27M-
Total Current Assets
Property Plant & Equipment-1.8M---1.77M---1.74M
Accumulated Depreciation-1.22M---1.08M---1.04M
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets18.31M10.54M7.73M6.92M5.3M7.15M14.41M14.5M11.51M12.33M
Total Assets
Notes Payable-1.15M--------
Accounts Payable--1.12M1.38M1.45M3.33M1.94M---
Current Portion Long-Term Debt6.84M6.71M5.43M5.45M5.48M2.6M3.82M3.76M3.83M3.84M
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus10.36M10.36M9.74M9.72M9.7M9.65M9.86M9.78M9.7M9.62M
Retained Earnings30.43M30.28M38.11M37.49M27.24M27.07M28.1M27.15M25.99M25.06M
Treasury Stock----------
Other Liabilities6.02M4.46M3.66M2.87M2.09M1.79M3.72M3.8M4.82M4.42M
Shareholders Equity46.88M45.17M51.58M50.14M39.09M38.57M41.75M40.79M40.57M39.17M
Total Liabilities & Shareholders Equity54.47M52.93M59.85M59.19M47.6M46.19M48.62M45.56M45.27M43.81M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at Yew Bio Pharm historical stock prices and the current Yew Bio Pharm stock price can tell you how the stock price has moved, whereas the Yew Bio Pharm PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: YEWB total assets, which was at $54.47M for 2018 Q1 is a balance sheet item representing value of what Yew Bio Pharm owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Yew Bio Pharm's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for YEWB stock stand at $7.59M.

Yew Bio Pharm Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio